Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes
Bradley A. Hamilton, J. Fraser Wright
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Addressing high dose AAV toxicity – ‘one and done’ or ‘slower and lower’?
Takashi Kishimoto, R. Jude Samulski
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 9, pp. 1067-1071
Open Access | Times Cited: 112
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa
Shireen V. Guide, Mercedes E. González, Işın Sinem Bağcı, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 24, pp. 2211-2219
Open Access | Times Cited: 112
rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
Weiran Shen, Shengjiang Liu, Li Ou
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 87
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Motahareh Arjomandnejad, Ishani Dasgupta, Terence R. Flotte, et al.
BioDrugs (2023) Vol. 37, Iss. 3, pp. 311-329
Open Access | Times Cited: 74
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
Stephanie M. Salabarria, Manuela Corti, Kirsten E. Coleman, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 1
Open Access | Times Cited: 52
Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates
Xinhong Chen, Damien A. Wolfe, Dhanesh Sivadasan Bindu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Engineering approaches for RNA-based and cell-based osteoarthritis therapies
Carlisle R. DeJulius, Bonnie L. Walton, Juan M. Colazo, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 81-100
Closed Access | Times Cited: 28
Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
Tong‐Yuan Yang, Manuela Braun, Wibke Lembke, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 26, pp. 471-494
Open Access | Times Cited: 49
Cytokine Responses to Adenovirus and Adenovirus Vectors
Svetlana Atasheva, Dmitry M. Shayakhmetov
Viruses (2022) Vol. 14, Iss. 5, pp. 888-888
Open Access | Times Cited: 40
Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases
Shaoxue Zeng, Yingying Chen, Fanfan Zhou, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114965-114965
Open Access | Times Cited: 23
Understanding AAV vector immunogenicity: from particle to patient
Bijay Dhungel, Ian Winburn, Candida da Fonseca Pereira, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1260-1288
Open Access | Times Cited: 15
Practical Considerations for Delandistrogene Moxeparvovec Gene Therapy in Patients With Duchenne Muscular Dystrophy
Jerry R. Mendell, Crystal M. Proud, Craig M. Zaidman, et al.
Pediatric Neurology (2024) Vol. 153, pp. 11-18
Open Access | Times Cited: 13
Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo
Martine Aubert, Anoria K. Haick, Daniel E. Strongin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution
Artyom Kachanov, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2112-2193
Closed Access | Times Cited: 12
Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina
Aurélien Leray, Pierre-Alban Lalys, Juliette Varin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116148-116148
Open Access | Times Cited: 11
Gene Therapy Developments for Pompe Disease
Zeenath Unnisa, John K. Yoon, Jeffrey W. Schindler, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 302-302
Open Access | Times Cited: 36
Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
Duohao Ren, Sylvain Fisson, Deniz Dalkara, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1973-1973
Open Access | Times Cited: 32
Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy
Natalie L. Goedeker, Sachi D. Dharia, Danielle A. Griffin, et al.
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 22
Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery
Eloïse Hudry, Fumiaki Aihara, Emily K. Meseck, et al.
Molecular Therapy (2023) Vol. 31, Iss. 10, pp. 2999-3014
Open Access | Times Cited: 20
Progress of nanoparticle drug delivery system for the treatment of glioma
Guogang Lai, Hao Wu, Kaixia Yang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 8
Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases
Federica Esposito, Fabio Dell’Aquila, Manuel Rhiel, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101619-101619
Open Access | Times Cited: 7
Advances in Ophthalmic Optogenetics: Approaches and Applications
Philipp P. Prosseda, Matthew Tran, Tia J. Kowal, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 269-269
Open Access | Times Cited: 27
A Structural View at Vaccine Development against M. tuberculosis
Maria Romanò, Flavia Squeglia, Eliza Kramarska, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 317-317
Open Access | Times Cited: 16
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, et al.
Antibodies (2023) Vol. 12, Iss. 3, pp. 46-46
Open Access | Times Cited: 15
Development of CNS tropic AAV1-like variants with reduced liver-targeting following systemic administration in mice
Matthieu Drouyer, Jessica Merjane, Deborah Nazareth, et al.
Molecular Therapy (2024) Vol. 32, Iss. 3, pp. 818-836
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top